Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis.

Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM; members of the guideline committee.

Z Gastroenterol. 2015 Dec;53(12):1447-95. doi: 10.1055/s-0041-107379. Epub 2015 Dec 14.

2.

Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progression.

Vay C, Hosch SB, Stoecklein NH, Klein CA, Vallböhmer D, Link BC, Yekebas EF, Izbicki JR, Knoefel WT, Scheunemann P.

PLoS One. 2014 Nov 14;9(11):e109026. doi: 10.1371/journal.pone.0109026. eCollection 2014.

3.

Stapled hemorrhoidopexy versus Milligan-Morgan hemorrhoidectomy in circumferential third-degree hemorrhoids: long-term results of a randomized controlled trial.

Kim JS, Vashist YK, Thieltges S, Zehler O, Gawad KA, Yekebas EF, Izbicki JR, Kutup A.

J Gastrointest Surg. 2013 Jul;17(7):1292-8. doi: 10.1007/s11605-013-2220-7. Epub 2013 May 14.

PMID:
23670518
4.

EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer.

Vashist YK, Trump F, Gebauer F, Kutup A, Güngör C, Kalinin V, Muddasar R, Vettorazzi E, Yekebas EF, Brandt B, Pantel K, Izbicki JR.

Target Oncol. 2014 Mar;9(1):43-52. doi: 10.1007/s11523-013-0260-2. Epub 2013 Feb 2.

PMID:
23377570
5.

The "North German Tumor Bank of Colorectal Cancer": status report after the first 2 years of support by the German Cancer Aid Foundation.

Oberländer M, Linnebacher M, König A, Bogoevska V, Brodersen C, Kaatz R, Krohn M, Hackmann M, Ingenerf J, Christoph J, Mate S, Prokosch HU, Yekebas EF, Thorns C, Büning J, Prall F, Uhlig R, Roblick UJ, Izbicki JR, Klar E, Bruch HP, Vollmar B, Habermann JK; ColoNet consortium.

Langenbecks Arch Surg. 2013 Feb;398(2):251-8. doi: 10.1007/s00423-012-1043-4. Epub 2013 Jan 8.

PMID:
23292500
6.

[Method report to the S3 guideline chronic pancreatitis: definition, etiology, diagnostics and conservative, interventional endoscopic and surgical therapy of the chronic pancreatitis].

Hoffmeister A, Mayerle J, Dathe K, Mössner J, Lerch MM; Mitglieder der Leitlinienkommission.

Z Gastroenterol. 2012 Nov;50(11):1225-36. doi: 10.1055/s-0032-1325447. Epub 2012 Nov 13. German. No abstract available.

PMID:
23150112
7.

[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)].

Chronic Pancreatitis German Society of Digestive and Metabolic Diseases (DGVS), Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM.

Z Gastroenterol. 2012 Nov;50(11):1176-224. doi: 10.1055/s-0032-1325479. Epub 2012 Nov 13. German. No abstract available.

PMID:
23150111
8.

Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with "classical" stump closure (Nissen-Bsteh).

Vashist YK, Yekebas EF, Gebauer F, Tachezy M, Bachmann K, König A, Kutup A, Izbicki JR.

Langenbecks Arch Surg. 2012 Dec;397(8):1243-9. doi: 10.1007/s00423-012-0990-0. Epub 2012 Aug 19.

PMID:
22903877
9.

Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.

Vashist YK, Effenberger KE, Vettorazzi E, Riethdorf S, Yekebas EF, Izbicki JR, Pantel K.

Ann Surg. 2012 Jun;255(6):1105-12. doi: 10.1097/SLA.0b013e3182565b0b.

PMID:
22580852
10.

Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment?

Kutup A, Vashist YK, Groth S, Vettorazzi E, Yekebas EF, Soehendra N, Izbicki JR.

Endoscopy. 2012 Jun;44(6):572-6. doi: 10.1055/s-0032-1308950. Epub 2012 Apr 23.

PMID:
22528672
11.

Is Toupet fundoplication the procedure of choice for treating gastroesophageal reflux disease? Results of a prospective randomized experimental trial comparing three major antireflux operations in a porcine model.

Bachmann K, Wachowiak R, Rempf C, Vashist Y, Mann O, Yekebas EF, Izbicki JR, Gawad KA.

Surg Endosc. 2011 Oct;25(10):3235-44. doi: 10.1007/s00464-011-1699-9. Epub 2011 May 14.

PMID:
21573715
12.

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.

Vashist YK, Uzungolu G, Kutup A, Gebauer F, Koenig A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki JR, Yekebas EF.

J Surg Oncol. 2011 Sep 1;104(3):305-11. doi: 10.1002/jso.21926. Epub 2011 Apr 14.

PMID:
21495030
13.

The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.

Vashist YK, Kutup A, Musici S, Yekebas EF, Mina S, Uzunoglu G, Zehler O, Koenig A, Cataldegirmen G, Bockhorn M, Effenberger K, Kalinin V, Pantel K, Izbicki JR.

Cell Oncol (Dordr). 2011 Aug;34(4):281-8. doi: 10.1007/s13402-011-0016-x. Epub 2011 Feb 22.

PMID:
21340746
14.

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.

Vashist YK, Uzunoglu G, Deutsch L, Kalinin V, Zehler O, Alzadjali A, Kutup A, Izbicki JR, Yekebas EF.

J Surg Res. 2011 Apr;166(2):e121-7. doi: 10.1016/j.jss.2010.11.898. Epub 2010 Dec 18.

PMID:
21236443
15.

Chronic pancreatitis: modern surgical management.

Bachmann K, Izbicki JR, Yekebas EF.

Langenbecks Arch Surg. 2011 Feb;396(2):139-49. doi: 10.1007/s00423-010-0732-0. Epub 2010 Dec 21. Review.

PMID:
21174215
16.

Arterial en bloc resection for pancreatic carcinoma.

Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas EF, Izbicki JR.

Br J Surg. 2011 Jan;98(1):86-92. doi: 10.1002/bjs.7270. Epub 2010 Oct 25.

PMID:
21136564
17.

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.

Vashist YK, Loos J, Dedow J, Tachezy M, Uzunoglu G, Kutup A, Yekebas EF, Izbicki JR.

Ann Surg Oncol. 2011 Apr;18(4):1130-8. doi: 10.1245/s10434-010-1383-7. Epub 2010 Oct 28.

PMID:
20981494
18.

Chronic pancreatitis complicated by cavernous transformation of the portal vein: contraindication to surgery?

Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist YK, Yekebas EF, Izbicki JR, Mann O.

Surgery. 2011 Mar;149(3):321-8. doi: 10.1016/j.surg.2010.06.011. Epub 2010 Aug 4.

PMID:
20684965
19.

Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.

Kutup A, Yekebas EF, Izbicki JR.

Recent Results Cancer Res. 2010;182:115-25. doi: 10.1007/978-3-540-70579-6_10. Review.

PMID:
20676876
20.

Quo vadis STARR? A prospective long-term follow-up of stapled transanal rectal resection for obstructed defecation syndrome.

Zehler O, Vashist YK, Bogoevski D, Bockhorn M, Yekebas EF, Izbicki JR, Kutup A.

J Gastrointest Surg. 2010 Sep;14(9):1349-54. doi: 10.1007/s11605-010-1261-4. Epub 2010 Jul 2.

PMID:
20596788
Items per page

Supplemental Content

Loading ...
Write to the Help Desk